Vaccination Against Androgen Receptor Splice Variants to Immunologically Target Prostate Cancer
<b>Background/Objectives</b>: Androgen receptor (AR) expression and signaling are critical for the progression of prostate cancer and have been the therapeutic focus of prostate cancer for over 50 years. While a variety of agents have been developed to target this axis, many of these fai...
Saved in:
| Main Authors: | Robert D. Marek, Selena Halabi, Mu-En Wang, Jason McBane, Junping Wei, Tao Wang, Xiao Yang, Congxiao Liu, Gangjun Lei, Herbert Kim Lyerly, Ming Chen, Timothy N. Trotter, Zachary C. Hartman |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2024-11-01
|
| Series: | Vaccines |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2076-393X/12/11/1273 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Regulation of androgen receptor variants in prostate cancer
by: Yezi Zhu, et al.
Published: (2020-07-01) -
Long-term systemic androgen deprivation partially modulates neuroinflammation in male App NL−G−F/NL−G−F mice
by: Kasumi Maekawa, et al.
Published: (2025-04-01) -
Androgen receptor as a potential therapeutic target in castration-resistant prostate cancer: a bibliometric analysis (2005–2024)
by: Jiexiang Zhang, et al.
Published: (2025-07-01) -
The correlation between the expression of androgen receptor splice variant-7 (AR-V7) protein with the time of occurrence of castration-resistant prostate cancer and overall survival in prostate cancer in Indonesian population
by: Indrawarman Soerohardjo, et al.
Published: (2025-02-01) -
Editorial: Androgen-dependent diseases and their treatment
by: Marisa Cabeza
Published: (2024-12-01)